|
-
Merck Sharp & Dohme New Zealand (MSDNZ) has gained registration for its osteoporosis medication FOSAMAX PLUS™ 5600 IU. MSDNZ Managing Director, Alister Brown, says "This will be welcome news for the many doctors who have been calling for increased Vitamin D supplementation in osteoporosis medication. Click here for more.
-
New Zealanders with Type 2 diabetes now have access to a new medicine which is significantly less likely to cause weight gain or dangerously low blood sugar; thanks to Merck Sharp & Dohme New Zealand's (MSDNZ) once-daily tablet, JANUVIA® (sitagliptin, MSD), which has been approved for use in New Zealand. Click here for more.
-
The new PROPECIA® (finasteride, MSD) advertising campaign has recently gone to air. Titled "Propecia Twins" and starring the actors from the initial ad, it follows on from the original story but now we meet the twins four years later and there are some noticeable changes! Click here for more.
-
Doctors can now upgrade osteoporosis patients to FOSAMAX PLUS and initiate new patients straight onto the new, once-weekly combination treatment. Click here for more.
-
Final results were presented from the largest and longest arthritis study programme ever undertaken, the MEDAL (Multinational Etoricoxib and Diclofenac Arthritis Long-Term) Programme. Click here for more.
Click here for more details on Executive Speeches & Webcasts
Media Archive
THINGS TO KNOW BEFORE USING FOSAMAX (alendronate) 70 mg tablets or FOSAMAX Plus (alendronate /colecalciferol) 70 mg/ 70mcg (2800 IU Vitamin D3) tablets: FOSAMAX is indicated for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures). FOSAMAX Plus is indicated for the treatment of osteoporosis in select patients where Vitamin D supplementation is recommended. FOSAMAX or FOSAMAX Plus should not be taken by patients who have a hypersensitivity reaction, food pipe (oesophageal) abnormalities, low calcium (hypocalcaemia) and have an inability to stand/sit upright for 30mins. Precaution should be taken when administering FOSAMAX or FOSAMAX Plus to patients with active upper gastrointestinal problems, impaired renal function and calcium or vitamin D deficiency. Common side effects are: abdominal pain, dyspepsia, food pipe (oesophageal) ulcer, difficulty swallowing (dysphagia), abdominal distension, musculoskeletal pain, constipation, diarrhoea, flatulence and headache. FOSAMAX is a prescription only medicine, fully subsidised under special authority for those who meet specified criteria. A prescription charge will apply. FOSAMAX Plus is a private purchase prescription only medicine that the patient will need to pay for. Price may vary across different pharmacies. Consult your doctor to see if FOSAMAX is right for you, a normal doctors visit fee will usually apply. Use only as directed and if symptoms continue or you have side effects, see your doctor, pharmacist or health professional. Marketed by: Merck Sharp & Dohme (NZ) Limited, Newmarket, Auckland. For detailed prescribing information, consult the data sheet or consumer medicine information phone 0800 500 673, or refer to the Medsafe website www.medsafe.govt.nz. [MPI-FSM/ FSP-1]
THINGS TO KNOW BEFORE USING PROPECIA (finasteride) 1mg tablet:
PROPECIA is indicated for the treatment of men with male pattern hair loss (androgenetic alopecia) to increase hair growth and prevent further hair loss. PROPECIA should not be taken by women and patients who have a hypersensitivity reaction. Precaution should be taken in regard to pregnant women handling PROPECIA tablets. A decrease of serum prostate-specific-antigen (PSA) may be seen upon testing. Common side effects are: decreased libido, erectile dysfunction, ejaculation disorder, decreased volume of ejaculate (each of these adverse effects occurred in less than two men in one hundred), testicular pain, breast tenderness/enlargement and hypersensitivity. PROPECIA is a private purchase prescription medicine that the patient will need to pay for. Price may vary across different pharmacies. Consult your doctor to see if PROPECIA is right for you, a normal doctors visit fee will usually apply. Use only as directed and if symptoms continue or you have side effects, see your doctor, pharmacist or health professional. Marketed by: Merck Sharp & Dohme (NZ) Limited, Newmarket, Auckland For detailed prescribing information, consult the data sheet or consumer medicine information on 0800 500 673 or refer to the Medsafe website www.medsafe.govt.nz . [MPI-PPC-2]
|
